Invasive group B streptococcus disease with recurrence and in multiples: towards a better understanding of GBS late-onset sepsis

  • Group B Streptococcus (GBS) is a common intestinal colonizer during the neonatal period, but also may cause late-onset sepsis or meningitis in up to 0.5% of otherwise healthy colonized infants after day 3 of life. Transmission routes and risk factors of this late-onset form of invasive GBS disease (iGBS) are not fully understood. Cases of iGBS with recurrence (n=25) and those occurring in parallel in twins/triplets (n=32) from the UK and Ireland (national surveillance study 2014/15) and from Germany and Switzerland (retrospective case collection) were analyzed to unravel shared (in affected multiples) or fixed (in recurrent disease) risk factors for GBS disease. The risk of iGBS among infants from multiple births was high (17%), if one infant had already developed GBS disease. The interval of onset of iGBS between siblings was 4.5 days and in recurrent cases 12.5 days. Disturbances of the individual microbiome, including persistence of infectious foci are suggested e.g. by high usage of perinatal antibiotics in mothers of affected multiples, and by the association of an increased risk of recurrence with a short term of antibiotics [aOR 4.2 (1.3-14.2), P=0.02]. Identical GBS serotypes in both recurrent infections and concurrently infected multiples might indicate a failed microbiome integration of GBS strains that are generally regarded as commensals in healthy infants. The dynamics of recurrent GBS infections or concurrent infections in multiples suggest individual patterns of exposure and fluctuations in host immunity, causing failure of natural niche occupation.
Metadaten
Author:Mirjam FreudenhammerORCiDGND, Konstantinos Karampatsas, Kirsty Le Doare, Fabian Lander, Jakob ArmannORCiDGND, Daniel Acero Moreno, Margaret Boyle, Horst BuxmannORCiDGND, Ruth Campbell, Victoria Chalker, Robert Cunney, Lorraine Doherty, Eleri Davies, Androulla Efstratiou, Roland EllingORCiDGND, Matthias EndmannORCiDGND, Jochen EssersGND, Roland HentschelORCiDGND, Christine E. Christine E. Jones, Steffen KallsenGND, Georgia Kapatai, Marcus KrügerORCiDGND, Shamez Ladhani, Theresa Lamagni, Diane Lindsay, Mary Meehan, Catherine P. O’Sullivan, Darshana Patel, Arlene J. Reynolds, Claudia RollGND, Sven SchulzkeGND, Andrew Smith, Anja SteinGND, Axel von der WenseGND, Egbert Voss, Christian Wieg, Christoph HärtelGND, Paul T. Heath, Philipp HennekeORCiDGND
URN:urn:nbn:de:hebis:30:3-620426
DOI:https://doi.org/10.3389/fimmu.2021.617925
ISSN:1664-3224
Parent Title (English):Frontiers in immunology
Publisher:Frontiers Media
Place of publication:Lausanne
Document Type:Article
Language:English
Date of Publication (online):2021/06/02
Date of first Publication:2021/06/02
Publishing Institution:Universitätsbibliothek Johann Christian Senckenberg
Release Date:2023/01/09
Tag:group B Streptococcus; late-onset sepsis; microbiome; multiples; recurrence
Volume:12
Issue:art. 617925
Article Number:617925
Page Number:12
First Page:1
Last Page:12
Note:
This work was supported by the Else-Kröner-Fresenius Foundation; the German Ministry of Education and Research (grants 01EO0803, 01GL1746A, 01EK1602A to PH); the German Research Council (grants HE3127/9, HE3127/12, SFB/TRR167 to PH, 413517907 as an IMM-PACT Clinician Scientist fellowship to MF) and Meningitis Now (grant 13.0189). The article processing charge was funded by the Baden-Wuerttemberg Ministry of Science, Research and Art and the University of Freiburg in the funding programme Open Access Publishing.
Institutes:Medizin / Medizin
Dewey Decimal Classification:6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit
Sammlungen:Universitätspublikationen
Licence (German):License LogoCreative Commons - Namensnennung 4.0